316 related articles for article (PubMed ID: 24360074)
1. Erythrocyte oxidative stress in patients with calcium oxalate stones correlates with stone size and renal tubular damage.
Ma MC; Chen YS; Huang HS
Urology; 2014 Feb; 83(2):510.e9-17. PubMed ID: 24360074
[TBL] [Abstract][Full Text] [Related]
2. Renal tubular cell damage and oxidative stress in renal stone patients and the effect of potassium citrate treatment.
Tungsanga K; Sriboonlue P; Futrakul P; Yachantha C; Tosukhowong P
Urol Res; 2005 Feb; 33(1):65-9. PubMed ID: 15565439
[TBL] [Abstract][Full Text] [Related]
3. Editorial comment.
Eisner BH
Urology; 2014 Feb; 83(2):510.e16. PubMed ID: 24360071
[No Abstract] [Full Text] [Related]
4. Reply: To PMID 24360071.
Huang HS; Ma MC
Urology; 2014 Feb; 83(2):510.e16-7. PubMed ID: 24360069
[No Abstract] [Full Text] [Related]
5. Lipid peroxidation and its correlations with urinary levels of oxalate, citric acid, and osteopontin in patients with renal calcium oxalate stones.
Huang HS; Ma MC; Chen CF; Chen J
Urology; 2003 Dec; 62(6):1123-8. PubMed ID: 14665375
[TBL] [Abstract][Full Text] [Related]
6. Oxalate metabolism in renal stone disease with special reference to calcium metabolism and intestinal absorption.
Lindsjö M
Scand J Urol Nephrol Suppl; 1989; 119():1-53. PubMed ID: 2669121
[TBL] [Abstract][Full Text] [Related]
7. Vitamin E therapy prevents hyperoxaluria-induced calcium oxalate crystal deposition in the kidney by improving renal tissue antioxidant status.
Thamilselvan S; Menon M
BJU Int; 2005 Jul; 96(1):117-26. PubMed ID: 15963133
[TBL] [Abstract][Full Text] [Related]
8. Stone size limits the use of Hounsfield units for prediction of calcium oxalate stone composition.
Stewart G; Johnson L; Ganesh H; Davenport D; Smelser W; Crispen P; Venkatesh R
Urology; 2015 Feb; 85(2):292-5. PubMed ID: 25481232
[TBL] [Abstract][Full Text] [Related]
9. Oxalate at physiological urine concentrations induces oxidative injury in renal epithelial cells: effect of α-tocopherol and ascorbic acid.
Thamilselvan V; Menon M; Thamilselvan S
BJU Int; 2014 Jul; 114(1):140-50. PubMed ID: 24460843
[TBL] [Abstract][Full Text] [Related]
10. Uric acid: an abettor or protector in calcium oxalate urolithiasis? Biochemical study in stone formers.
Srinivasan S; Kalaiselvi P; Sakthivel R; Pragasam V; Muthu V; Varalakshmi P
Clin Chim Acta; 2005 Mar; 353(1-2):45-51. PubMed ID: 15698589
[TBL] [Abstract][Full Text] [Related]
11. High Sodium-Induced Oxidative Stress and Poor Anticrystallization Defense Aggravate Calcium Oxalate Crystal Formation in Rat Hyperoxaluric Kidneys.
Huang HS; Ma MC
PLoS One; 2015; 10(8):e0134764. PubMed ID: 26241473
[TBL] [Abstract][Full Text] [Related]
12. Renal oxidative vulnerability due to changes in mitochondrial-glutathione and energy homeostasis in a rat model of calcium oxalate urolithiasis.
Meimaridou E; Lobos E; Hothersall JS
Am J Physiol Renal Physiol; 2006 Oct; 291(4):F731-40. PubMed ID: 16670437
[TBL] [Abstract][Full Text] [Related]
13. [Risk factors for the formation of urinary calcium-containing stones in diabetics].
Liu JG; Hu M; He XQ
Zhonghua Nei Ke Za Zhi; 1989 Nov; 28(11):649-53, 699-700. PubMed ID: 2632175
[TBL] [Abstract][Full Text] [Related]
14. [The effect of hemodialysis on some parameters of the antioxidant system in the blood of patients with chronic renal failure].
Olszewska M
Ann Acad Med Stetin; 2004; 50(1):41-52. PubMed ID: 16871743
[TBL] [Abstract][Full Text] [Related]
15. Atorvastatin inhibits renal crystal retention in a rat stone forming model.
Tsujihata M; Momohara C; Yoshioka I; Tsujimura A; Nonomura N; Okuyama A
J Urol; 2008 Nov; 180(5):2212-7. PubMed ID: 18804815
[TBL] [Abstract][Full Text] [Related]
16. Autophagy-endoplasmic reticulum stress inhibition mechanism of superoxide dismutase in the formation of calcium oxalate kidney stones.
Kang J; Sun Y; Deng Y; Liu Q; Li D; Liu Y; Guan X; Tao Z; Wang X
Biomed Pharmacother; 2020 Jan; 121():109649. PubMed ID: 31733571
[TBL] [Abstract][Full Text] [Related]
17. Calcium oxalate stone disease: role of lipid peroxidation and antioxidants.
Selvam R
Urol Res; 2002 Mar; 30(1):35-47. PubMed ID: 11942324
[TBL] [Abstract][Full Text] [Related]
18. Upper urinary tract stone analysis using X-ray diffraction: results from a tertiary referral centre in northern India.
Ahlawat R; Goel MC; Elhence A
Natl Med J India; 1996; 9(1):10-12. PubMed ID: 8713517
[TBL] [Abstract][Full Text] [Related]
19. Metabolic urinary correlates of calcium oxalate dihydrate in renal stones.
Asplin JR; Lingeman J; Kahnoski R; Mardis H; Parks JH; Coe FL
J Urol; 1998 Mar; 159(3):664-8. PubMed ID: 9474121
[TBL] [Abstract][Full Text] [Related]
20. Vitamin E attenuates crystal formation in rat kidneys: roles of renal tubular cell death and crystallization inhibitors.
Huang HS; Chen J; Chen CF; Ma MC
Kidney Int; 2006 Aug; 70(4):699-710. PubMed ID: 16807540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
